Question
Is Serrapeptase legit?
In context of Serrapeptase·Insufficient evidence56/100
In our editorial model, Serrapeptase maps to a Insufficient evidence verdict at 56/100 overall (evidence 48/100, safety 72/100, hype gap 64/100). Post-surgical inflammation marketing; Sinus congestion. Typical label framing: Products vary; enteric coating required for activity.
Full ingredient file
This page is a short answer. Mechanisms, dosing notes, sources, and the rest of the verdict live on the hub for Serrapeptase.
Open Serrapeptase verdictOther questions on Serrapeptase
A few more focused pages for the same ingredient (we keep lists short on purpose).